✦ LIBER ✦

North Central Cancer Treatment Group N0531: Phase II Trial of Weekly Albumin-Bound Paclitaxel (ABI-007; Abraxane®) in Combination with Gemcitabine in Patients with Metastatic Breast Cancer

✍ Scribed by Alvaro Moreno-Aspitia; Edith A. Perez

Book ID: 115075684
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 473 KB
Volume: 6
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2005.n.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly nab (nanopartic

Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane(R)) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

✍ Roy, V.; LaPlant, B. R.; Gross, G. G.; Bane, C. L.; Palmieri, F. M. 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 71 KB

P316 Phase II study of weekly albumin-bo

P316 Phase II study of weekly albumin-bound paclitaxel combined with cisplatin in patients with advanced breast cancer

✍ X. Hu; B. Wang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Phase II Multicenter Trial of Albumin-Bo

Phase II Multicenter Trial of Albumin-Bound Paclitaxel and Capecitabine in First-Line Treatment of Patients With Metastatic Breast Cancer

✍ Lee S. Schwartzberg; Francis P. Arena; David M. Mintzer; Amanda L. Epperson; Mar 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 391 KB

Higher rate of skin rash in a phase II t

Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients

✍ Li Chen Tang, Bi Yun Wang, Si Sun, Jian Zhang, Zhen Jia, Yun Hua Lu… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 247 KB

A Phase II Study of Weekly Nanoparticle

A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast Cancer

✍ Barry Mirtsching; Thomas Cosgriff; Graydon Harker; Mark Keaton; Tarek Chidiac; M 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 350 KB

A phase II trial of nab-paclitaxel (ABI-

A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group Study, N057E1

✍ Lisa A. Kottschade; Vera J. Suman; Thomas Amatruda III; Robert R. McWilliams; Ba 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views